Tech Billionaires Bankroll Longevity Research to Extend Human Life
Tech billionaires are pouring money into longevity research, aiming to extend human lifespan and improve health. Jeff Bezos has reportedly invested in Altos Labs, while Brian Armstrong's NewLimit has raised $130 million. Vitalik Buterin has also donated significantly to the cause.
Armstrong, co-founder of Coinbase, launched NewLimit to tackle aging. He sees it as a 'significant human tragedy' and believes treatments could extend life. NewLimit aims to reprogram human genes through epigenetic targeting. Human trials are still years away, with current experiments focusing on liver and immune system cells.
Bezos, through his investment in Altos Labs, supports research into cellular reprogramming and rejuvenation. Meanwhile, Ethereum co-founder Buterin has donated an estimated $336 million to longevity research, including to SENS Research Foundation and Impetus Grants. Larry Ellison has also publicly expressed interest in and supported longevity research. Armstrong is optimistic about transformative breakthroughs, inspired by advancements in mRNA therapeutics and GLP-1 drugs.
These tech billionaires are funding high-risk, high-reward longevity research, driven by a desire to solve fundamental human challenges and push boundaries. While human trials for NewLimit are still years away, their investments signal a promising future for longevity research.
